rs142910512

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_ModerateBP6BP7BS1BS2

The NM_001165963.4(SCN1A):​c.4872G>A​(p.Leu1624Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000173 in 1,613,546 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. L1624L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00051 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00014 ( 0 hom. )

Consequence

SCN1A
NM_001165963.4 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:5

Conservation

PhyloP100: -0.120

Publications

1 publications found
Variant links:
Genes affected
SCN1A (HGNC:10585): (sodium voltage-gated channel alpha subunit 1) Voltage-dependent sodium channels are heteromeric complexes that regulate sodium exchange between intracellular and extracellular spaces and are essential for the generation and propagation of action potentials in muscle cells and neurons. Each sodium channel is composed of a large pore-forming, glycosylated alpha subunit and two smaller beta subunits. This gene encodes a sodium channel alpha subunit, which has four homologous domains, each of which contains six transmembrane regions. Allelic variants of this gene are associated with generalized epilepsy with febrile seizures and epileptic encephalopathy. Alternative splicing results in multiple transcript variants. The RefSeq Project has decided to create four representative RefSeq records. Three of the transcript variants are supported by experimental evidence and the fourth contains alternate 5' untranslated exons, the exact combination of which have not been experimentally confirmed for the full-length transcript. [provided by RefSeq, Oct 2015]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 2-165992403-C-T is Benign according to our data. Variant chr2-165992403-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 138986.
BP7
Synonymous conserved (PhyloP=-0.12 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000506 (77/152058) while in subpopulation AMR AF = 0.0019 (29/15256). AF 95% confidence interval is 0.00136. There are 0 homozygotes in GnomAd4. There are 41 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 77 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001165963.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN1A
NM_001165963.4
MANE Select
c.4872G>Ap.Leu1624Leu
synonymous
Exon 29 of 29NP_001159435.1P35498-1
SCN1A
NM_001202435.3
c.4872G>Ap.Leu1624Leu
synonymous
Exon 28 of 28NP_001189364.1P35498-1
SCN1A
NM_001353948.2
c.4872G>Ap.Leu1624Leu
synonymous
Exon 27 of 27NP_001340877.1P35498-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN1A
ENST00000674923.1
MANE Select
c.4872G>Ap.Leu1624Leu
synonymous
Exon 29 of 29ENSP00000501589.1P35498-1
SCN1A
ENST00000303395.9
TSL:5
c.4872G>Ap.Leu1624Leu
synonymous
Exon 28 of 28ENSP00000303540.4P35498-1
SCN1A
ENST00000375405.7
TSL:5
c.4839G>Ap.Leu1613Leu
synonymous
Exon 26 of 26ENSP00000364554.3P35498-2

Frequencies

GnomAD3 genomes
AF:
0.000500
AC:
76
AN:
151944
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000846
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00190
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.000279
AC:
70
AN:
251048
AF XY:
0.000221
show subpopulations
Gnomad AFR exome
AF:
0.000862
Gnomad AMR exome
AF:
0.000869
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000168
Gnomad OTH exome
AF:
0.000979
GnomAD4 exome
AF:
0.000138
AC:
202
AN:
1461488
Hom.:
0
Cov.:
31
AF XY:
0.000127
AC XY:
92
AN XY:
727066
show subpopulations
African (AFR)
AF:
0.00117
AC:
39
AN:
33444
American (AMR)
AF:
0.000873
AC:
39
AN:
44694
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53414
Middle Eastern (MID)
AF:
0.000694
AC:
4
AN:
5762
European-Non Finnish (NFE)
AF:
0.0000810
AC:
90
AN:
1111724
Other (OTH)
AF:
0.000480
AC:
29
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
13
25
38
50
63
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000506
AC:
77
AN:
152058
Hom.:
0
Cov.:
31
AF XY:
0.000552
AC XY:
41
AN XY:
74290
show subpopulations
African (AFR)
AF:
0.000867
AC:
36
AN:
41502
American (AMR)
AF:
0.00190
AC:
29
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5134
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
67956
Other (OTH)
AF:
0.00190
AC:
4
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000319
Hom.:
0
Bravo
AF:
0.000786
Asia WGS
AF:
0.000289
AC:
1
AN:
3476
EpiCase
AF:
0.000218
EpiControl
AF:
0.000237

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
not provided (2)
-
-
1
Developmental and epileptic encephalopathy (1)
-
1
-
Generalized epilepsy with febrile seizures plus, type 2 (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
Migraine, familial hemiplegic, 3 (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
5.9
DANN
Benign
0.69
PhyloP100
-0.12
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142910512; hg19: chr2-166848913; API